Loading organizations...
Key people at Medical Device Startup.
CMR Surgical develops robotic-assisted surgical systems, with its Versius Plus platform designed for minimal access surgery. This modular system integrates advanced visualization, including vLimeLite fluorescence imaging, and a digital ecosystem. It provides real-time operational and procedural insights through applications like Versius Connect and Versius Team, enhancing surgical precision and efficiency.
Founded in 2014, CMR Surgical was established by Luke Hares, Keith Marshall, Paul Roberts, Mark Slack, and Martin Frost. Their insight arose from the limited global access to minimal invasive surgery, prompting them to expand its availability through technology. Mark Slack, a gynecologist, contributed vital clinical understanding to the company's development.
Hospitals and surgeons globally employ Versius Plus for advanced patient care. CMR Surgical's vision aims to transform surgery by making minimal access procedures universally accessible, thereby improving patient outcomes and operational efficiency. The company continuously evolves its platform to address dynamic demands in complex surgical environments.
Key people at Medical Device Startup.
Medical Device Startup refers to an emerging company in the medtech sector, but the query lacks a specific name, matching no exact entity in recent accelerator cohorts or top lists. Based on 2025 search results, it aligns with innovative startups like those in MedTech Innovator's 65-company cohort, focusing on diagnostics, surgical tools, regenerative medicine, and FemTech.[1][2] These companies typically develop hardware or devices addressing unmet clinical needs—such as clot removal catheters from Toro Neurovascular (Irvine, CA), which serve stroke patients by enabling one-pass thrombectomy in tortuous vessels, or Starling Medical (Houston), which transforms toilets into urine analysis labs for UTI and kidney monitoring, serving chronic patients via clinician dashboards.[6][1][2]
Growth momentum is strong: Selected from 1,500+ applicants, these startups gain mentorship, visibility, and funding pathways through programs like MedTech Innovator's four-month accelerator, positioning them for FDA milestones, clinical trials, and scaling in a market favoring AI-integrated diagnostics and minimally invasive robotics.[1][2][3]
Without a named founder or precise founding date for "Medical Device Startup," its backstory mirrors patterns in 2025 medtech cohorts: Many emerge from clinician-engineer collaborations addressing gaps in patient care. For instance, Toro Neurovascular likely stems from neurointerventional expertise, iterating on aspiration catheters amid rising stroke intervention demands, with early physician feedback driving tortuous vessel navigation.[6][1] Similarly, Starling Medical pivoted from chronic disease monitoring needs, leveraging toilet-based sensing for non-invasive UTI tracking, achieving insurance-reimbursed pilots.[6]
Pivotal moments include 2025 accelerator acceptances—e.g., MedTech Innovator's cohort from 1,500 applicants—providing mentorship and exposure, akin to CergenX securing FDA Breakthrough Designation via quality software.[1][2][3] This humanizes these ventures as clinician-led responses to real-world pain points like infection prevention (Garwood Medical) or neonatal surgery precision (SVAN Medical).[3][5]
Medical device startups ride the AI-medtech convergence wave, integrating diagnostics with robotics and wearables amid aging populations and post-pandemic telehealth demand. Timing is ideal: 2025 sees FDA programs like TAP accelerating approvals, while cohorts like MedTech Innovator amplify 1,500-applicant talent pools into ecosystem influencers.[1][2][3] Market forces—rising chronic disease burdens (UTIs, strokes) and minimally invasive preferences—favor them, with robotics (Point Robotics) cutting surgery costs and digital twins (Aisthesis Medical) enabling predictive care.[4][5]
They shape the ecosystem by democratizing access (e.g., home urine labs) and fostering collaborations, influencing incumbents like Shockwave Medical while drawing VC (e.g., TytoCare's $156M).[4] This counters legacy device slowness, driving precision medtech adoption.
For a Medical Device Startup like those in 2025 cohorts, expect FDA clearances, Series A raises, and pilot expansions by 2026, fueled by Breakthrough designations and insurer adoption. Trends like AI-ultrasound integration (Prometheus MedTech) and autonomous robotics will amplify growth, evolving their role from niche innovators to ecosystem shapers. Success hinges on clinical data proving outcomes, potentially mirroring CMR Surgical's $974M trajectory—watch for cohort standouts like Toro Neurovascular to redefine stroke care, tying back to their accelerator-forged momentum.[1][2][4][6]
